Literature DB >> 8616864

Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells.

A Peled1, D Zipori, V Rotter.   

Abstract

Apoptosis may involve p53-dependent and -independent pathways. Results presented here suggest a possible cooperation between these two types of pathways. M1/2 is a p53-nonproducer subclone that may undergo either a p53-independent apoptosis following growth factor deprivation or a p53-dependent apoptosis following reconstitution of wild-type p53 expression. The p53-independent apoptosis in these cells is a slow process occurring after a G0-G1 arrest. In contrast, the p53-dependent apoptosis is much more rapid and is characterized by early and late apoptotic phases, taking place in cell arrested at G0-G1 and S phase. The transition from early to late apoptosis correlated with the levels of the p53 protein. Concomitant induction of both apoptotic pathways accelerated cell death and facilitated the transition from early to late apoptotic phase. The interaction between these pathways is further supported by the finding that mutant p53 interferes with p53-independent apoptosis. Thus, although apoptosis can occur via either p53-dependent or -independent pathways, under certain conditions the two pathways may interact with each other.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616864

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Authors:  D Matas; A Sigal; P Stambolsky; M Milyavsky; L Weisz; D Schwartz; N Goldfinger; V Rotter
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

4.  A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

Authors:  Claudia Fabiola Méndez-Catalá; Svetlana Gretton; Alexander Vostrov; Elena Pugacheva; Dawn Farrar; Yoko Ito; France Docquier; Georgia-Xanthi Kita; Adele Murrell; Victor Lobanenkov; Elena Klenova
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

5.  Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.

Authors:  E Brambilla; A Negoescu; S Gazzeri; S Lantuejoul; D Moro; C Brambilla; J L Coll
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  Differential cell killing by lymphomagenic murine leukemia viruses occurs independently of p53 activation and mitochondrial damage.

Authors:  Suparna Nanua; Fayth K Yoshimura
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas.

Authors:  Anu T Singh; Manu Jaggi; Sudhanand Prasad; Sarjana Dutt; Gurvinder Singh; Kakali Datta; Praveen Rajendran; Vinod K Sanna; Rama Mukherjee; Anand C Burman
Journal:  Invest New Drugs       Date:  2008-03-06       Impact factor: 3.850

8.  DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.

Authors:  S K Alam; V K Yadav; S Bajaj; A Datta; S K Dutta; M Bhattacharyya; S Bhattacharya; S Debnath; S Roy; L A Boardman; T C Smyrk; J R Molina; S Chakrabarti; S Chowdhury; D Mukhopadhyay; S Roychoudhury
Journal:  Cell Death Differ       Date:  2015-10-23       Impact factor: 15.828

9.  microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.

Authors:  Gianna Carvalheira; Bruno Heidi Nozima; Janete Maria Cerutti
Journal:  Oncotarget       Date:  2015-09-29

10.  Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.

Authors:  Dadi Jiang; Catherine I Dumur; H Davis Massey; Viswanathan Ramakrishnan; Mark A Subler; Jolene J Windle
Journal:  PLoS One       Date:  2015-02-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.